Drug Shortage Report for AURO-AZITHROMYCIN
Report ID | 214410 |
Drug Identification Number | 02482371 |
Brand name | AURO-AZITHROMYCIN |
Common or Proper name | AURO-AZITHROMYCIN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 200MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 22.5mL |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-12-28 |
Actual start date | 2023-12-28 |
Estimated end date | 2024-02-15 |
Actual end date | 2024-02-12 |
Shortage status | Resolved |
Updated date | 2024-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-02-13 | English | Compare |
v9 | 2024-02-12 | French | Compare |
v8 | 2024-02-12 | English | Compare |
v7 | 2024-01-29 | French | Compare |
v6 | 2024-01-29 | English | Compare |
v5 | 2023-12-29 | English | Compare |
v4 | 2023-12-28 | French | Compare |
v3 | 2023-12-28 | English | Compare |
v2 | 2023-12-28 | French | Compare |
v1 | 2023-12-28 | English | Compare |
Showing 1 to 10 of 10